Bruce M. Camitta
#160,276
Most Influential Person Now
Bruce M. Camitta's AcademicInfluence.com Rankings
Bruce M. Camittaphilosophy Degrees
Philosophy
#9219
World Rank
#12747
Historical Rank
Logic
#6206
World Rank
#7698
Historical Rank
Download Badge
Philosophy
Why Is Bruce M. Camitta Influential?
(Suggest an Edit or Addition)Bruce M. Camitta's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. (2012) (955)
- Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. (2000) (585)
- Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. (1976) (536)
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. (2010) (512)
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. (2008) (489)
- Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). (2007) (432)
- A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. (1979) (416)
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. (2010) (390)
- Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region (2002) (385)
- Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. (2010) (372)
- Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. (2001) (326)
- Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. (1989) (287)
- Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. (2011) (286)
- Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. (1998) (273)
- Bone marrow transplantation for Fanconi anemia. (1995) (269)
- Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. (2007) (259)
- Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse (2013) (257)
- Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. (2007) (256)
- Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. (1982) (253)
- Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood (1996) (249)
- Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia (2011) (244)
- Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements (2003) (241)
- Selection of patients for bone marrow transplantation in severe aplastic anemia. (1975) (236)
- Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. (1994) (233)
- Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update (1983) (230)
- Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (2000) (222)
- Treatment of acute myelogenous leukemia in children and adults. (1980) (220)
- Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. (1989) (219)
- Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. (2013) (212)
- Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]. (2008) (199)
- Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. (2009) (184)
- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. (2012) (181)
- Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. (2010) (180)
- Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (2010) (172)
- Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. (2007) (170)
- ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. (2012) (165)
- Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (2005) (164)
- Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. (2000) (159)
- Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404). (2011) (159)
- Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. (1983) (149)
- Minimal residual disease detection in childhood precursor–B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study (2003) (148)
- Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study. (1986) (143)
- Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. (1995) (137)
- Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children (1990) (136)
- Bone marrow transplantation for severe aplastic anemia: has outcome improved? (1997) (136)
- Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. (2010) (135)
- Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404. (2016) (135)
- Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia (1998) (135)
- New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. (2000) (127)
- Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. (1997) (125)
- Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. (2012) (117)
- Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. (2012) (112)
- Methotrexate Accumulation and Folate Depletion in Cells as a Possible Mechanism of Chronic Toxicity to the Drug (1981) (111)
- What Is the Definition of Cure for Aplastic Anemia? (2000) (110)
- Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia (2006) (107)
- Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. (1980) (106)
- Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. (2012) (106)
- Prognostic factors in childhood acute myelogenous leukemia. (1987) (105)
- High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. (1996) (105)
- Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. (1989) (103)
- Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. (1991) (103)
- CELL WALL COMPOSITION AND VIRULENCE IN ESCHERICHIA COLI (1968) (101)
- Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. (1999) (101)
- Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome (1992) (100)
- Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission (2002) (99)
- Outcomes after induction failure in childhood acute lymphoblastic leukemia. (2012) (99)
- Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. (2002) (99)
- Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. (1995) (97)
- A comparison study of parental adaptation following a child's death at home or in the hospital. (1983) (93)
- Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. (1997) (92)
- Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group (2005) (89)
- Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia (2007) (89)
- Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. (1983) (89)
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. (2006) (89)
- Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. (2006) (87)
- Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults (1996) (86)
- Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study (1998) (84)
- Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group. (2010) (84)
- Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. (2012) (79)
- Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. (1998) (78)
- Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. (2012) (77)
- Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. (1996) (77)
- Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group. (2011) (77)
- Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study. (1994) (77)
- Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. (1998) (76)
- Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. (2008) (74)
- Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. (1994) (74)
- Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3) (2015) (70)
- Children's perceptions of their sibling's death at home or hospital: the precursors of differential adjustment. (1985) (67)
- Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: A prospective longitudinal study (2002) (67)
- Long‐term follow‐up of parental adjustment following a child's death at home or hospital (1989) (66)
- Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906 (2011) (66)
- Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia (1994) (66)
- Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. (1974) (66)
- Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. (1997) (65)
- HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. (2008) (64)
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. (2005) (64)
- Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. (2011) (62)
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement. (2012) (61)
- Home care for dying children: a nursing model. (1980) (61)
- T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin’s lymphoma: clinical and molecular follow-up (1998) (59)
- Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. (2013) (58)
- Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication. (2001) (58)
- Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation (1997) (58)
- The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. (2019) (58)
- Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. (1992) (56)
- Hepatopathy following irradiation and adriamycin (1978) (56)
- Rearrangement of CRLF 2 is associated with mutation of JAK kinases , alteration of IKZF 1 , Hispanic / Latino ethnicity , and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia * (2010) (55)
- Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research (2013) (55)
- Patterns of communication among pediatric patients with leukemia, parents, and physicians: prognostic disagreements and misunderstandings. (1981) (54)
- The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia (1976) (53)
- Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. (1978) (50)
- Primary cerebral germinoma and ventriculoperitoneal shunt metastasis (1981) (50)
- Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (2012) (50)
- Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia. (1987) (50)
- Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. (2007) (50)
- Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse: A Children's Oncology Group Study (POG 8866) (2011) (48)
- Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. (1989) (48)
- Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis (2016) (48)
- Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study. (1988) (47)
- Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma. (1983) (47)
- Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. (2005) (46)
- Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. (2008) (45)
- Autoimmune thyroiditis after bone marrow transplantation. (1990) (44)
- Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. (1988) (44)
- Myelofibrosis-myeloid metaplasia in childhood. (1975) (44)
- Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. (2001) (44)
- Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor. (1983) (44)
- Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation. (1984) (42)
- Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report. (2017) (41)
- Severe aplastic anaemia: a prospective study of the effect of androgens or transplantation on haematological recovery and survival. (1978) (39)
- Intensive Alternating Drug Pairs After Remission Induction for Treatment of Infants With Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Pilot Study (1998) (38)
- Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031. (2007) (38)
- Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T‐cell leukemia (1987) (38)
- Imatinib resistant BCR‐ABL1 mutations at relapse in children with Ph+ALL: a Children's Oncology Group (COG) study (2012) (38)
- Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia (2007) (38)
- CRITERIA FOR SEVERE APLASTIC ANAEMIA (1988) (37)
- Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. (2002) (37)
- Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma (2008) (35)
- Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. (2013) (35)
- Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results. (1990) (35)
- Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. (2000) (34)
- Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. (2014) (34)
- DETECTION OF GENETICALLY DETERMINED HISTOCOMPATIBILITY ANTIGEN DIFFERENCES BETWEEN HL‐A IDENTICAL AND MLC NONREACTIVE SIBLINGS (1976) (34)
- Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study. (1998) (34)
- Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis. (1982) (33)
- Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407 (2012) (33)
- Outcome modeling with CRLF 2 , IKZF 1 , JAK , and minimal residual disease in pediatric acute lymphoblastic leukemia : a Children ’ s Oncology Group Study (2012) (33)
- Allergic Reactions to E. coli L-Asparaginase Do Not Affect Outcome in Childhood B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group Study (2007) (32)
- Unrelated donor marrow transplants for severe acquired aplastic anemia. (1992) (31)
- PharmGKB Update: II. CYP3A5, Cytochrome P450, Family 3, Subfamily A, Polypeptide 5 (2004) (31)
- Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy. (1990) (30)
- Utilization of hospice/home care in pediatric oncology A national survey (1986) (27)
- Hepatic ultrastructure in leukemic children treated with methotrexate and 6‐mercaptopurine (1983) (27)
- ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE (2013) (27)
- Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party (2010) (27)
- Biology and treatment of acute lymphocytic leukemia in children. (1997) (26)
- Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study (2005) (25)
- Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndrome. (1993) (25)
- Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas. (1989) (25)
- Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. (2015) (24)
- Bone marrow transplantation for an infant with neutrophil dysfunction. (1977) (24)
- Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report. (1976) (24)
- The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study (2001) (24)
- Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. (1998) (24)
- Thyroid carcinoma following treatment for acute lymphoblastic leukemia (1980) (23)
- Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase. (1979) (23)
- Intensive alternating drug pairs for treatment of high‐risk childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study (1993) (22)
- Evaluation of cerebrospinal fluid mononuclear cells obtained from children with acute lymphocytic leukemia: advantages of combining cytomorphology and terminal deoxynucleotidyl transferase. (1983) (22)
- Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B—lineage acute lymphoblastic leukemia. A pediatric oncology group pilot study (1995) (22)
- Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry. (1992) (22)
- Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (2004) (22)
- Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. (2013) (21)
- Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone. (1977) (21)
- Methemoglobinemia in an infant treated with the folk remedy glycerited asafoetida. (1984) (20)
- The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft‐versus‐host disease in paediatric patients (2013) (20)
- Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome (2014) (19)
- Accumulation of High Levels of Methotrexate Polyglutamates in Lymphoblasts From Children With Hyperdiploid ( > 50 chromosomes ) B-Lineage Acute Lymphoblastic Leukemia : A Pediatric Oncology Group Study (2003) (19)
- Intensified PEG-L-asparaginase and Antimetabolite-based Therapy for Treatment of Higher Risk Precursor-B Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group (2007) (19)
- Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. (1992) (19)
- Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. (2009) (19)
- Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study. (1996) (19)
- Hla antigens and haplotypes in 200 patients with aplastic anemia. (1976) (19)
- Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. (1992) (18)
- Optic chiasm glioma associated with inappropriate secretion of antidiuretic hormone, cerebral ischemia, nonobstructive hydrocephalus and chronic ascites following ventriculoperitoneal shunting (1991) (18)
- Doxorubicin cardiomyopathy in children with left-sided Wilms tumor. (1982) (18)
- Multilocular renal cyst: electron microscopic evidence of pathogenesis. (1984) (18)
- Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders (1997) (17)
- Isolated Bilateral T‐Cell Renal Lymphoblastic Lymphoma (1986) (17)
- Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia. (1980) (17)
- Effect of abrupt discontinuation of high glucose infusion rates during parenteral nutrition. (1994) (17)
- Outcome of Children with Standard‐Risk T‐Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment Strategies (2016) (17)
- The role of viral infections in aplastic anemia. (1979) (16)
- Use of irradiated lymphocytes from immune donors for treatment of disseminated varicella. (1994) (16)
- Plasma Methotrexate, Red Blood Cell Methotrexate, and Red Blood Cell Folate Values and Outcome in Children With Precursor B-acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group (2012) (15)
- Cerebral toxoplasmosis in an immunocompromised host. A precise and rapid diagnosis by electron microscopy. (1986) (15)
- High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma. (2010) (14)
- Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders (2004) (14)
- Providing personalized prognostic information for adult leukemia survivors. (2013) (14)
- Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse. (1982) (14)
- Cardioprotection and safety of dexrazoxane (DRZ) in children treated for newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or advanced stage lymphoblastic leukemia (T-LL). (2012) (13)
- Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options (2010) (13)
- Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL (2006) (13)
- Optimizing Use of the Complete Blood Count (2012) (13)
- Caregiving Demands and Well-being in Parents of Children Treated With Outpatient or Inpatient Methotrexate Infusion: A Report From the Children’s Oncology Group (2014) (12)
- Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. (1998) (12)
- Pathogenesis and treatment of aplastic anemia. (1984) (12)
- Intensive sequential chemotherapy for children with acute myelogenous leukemia. (1990) (11)
- Effectiveness of a six‐drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children (1985) (11)
- Dental management of patients undergoing bone marrow transplantation for aplastic anemia. (1977) (11)
- Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG). (2007) (11)
- Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase. (1979) (10)
- Protein-energy nutritional status of pediatric cancer patients. (1981) (10)
- Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. (2007) (10)
- Antithoracic duct lymphocyte globulin. (1983) (9)
- Outcomes after HLA-Matched Sibling Transplants or Chemotherapy in Children with Acute Lymphoblastic Leukemia in a Second Remission after an Isolated Central Nervous System Relapse. (2006) (9)
- Antithoracic duct lymphocyte globulin [letter] (1983) (9)
- Acute erythroid hypoplasia in malnourished infant squirrel monkeys fed isolated soy protein. (1977) (9)
- Biology-Driven Classification of Childhood Acute Lymphoblastic Leukemia: A Combined Analysis of Prognostic Markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG). (2004) (9)
- Safety of delayed leucovorin "rescue" following high-dose methotrexate in children. (1978) (8)
- Prognostic Significance of Minimal Residual Disease (MRD) in Childhood B-Precursor ALL and Its Relation to Other Risk Factors. A Children’s Oncology Group (COG) Study. (2006) (8)
- Absidia corymbifera endocarditis: survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall. (2010) (8)
- Splenic Torsion in an Infant Associated with Secondary Disseminated Hemophilus influenzae Infection (1982) (8)
- Specific MLL Partner Genes in Infant Acute Lymphoblastic Leukemia (ALL) Associated with Outcome Are Linked to Age and White Blood Cell Count (WBC) at Diagnosis: A Report On the Children's Oncology Group (COG) P9407 Trial. (2009) (8)
- Dose Intensification of Methotrexate and Cytarabine During Intensified Continuation Chemotherapy for High-risk B-Precursor Acute Lymphoblastic Leukemia: POG 9406 A Report From the Children’s Oncology Group (2014) (8)
- Minimax two‐stage‐designs with applications to tissue banking case‐control studies (2002) (8)
- Cyclic neutropenia in identical twins. (1986) (7)
- Hematopoietic stem cell transplant (HSCT) versus intensive chemotherapy in infant acute lymphoblastic leukemia (ALL) (2007) (7)
- Outcomes of Children with First Marrow Relapse: Results from Children’s Oncology Group (COG) Study AALL01P2. (2006) (7)
- Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. (2015) (7)
- Aplastic Anemia: Alternative donor bone marrow transplantation for severe acquired aplastic anemia (1999) (6)
- A Randomized Comparative Study of Purged Autologous Bone Marrow Transplantation Versus Intensive Multiagent Consolidation Chemotherapy in First Remission of Acute Myeloid Leukemia in Children (Pediatric Oncology Group Study—POG 8821) (1997) (6)
- Prognostic Significance of Minimal Residual Disease (MRD) in Children with High Risk Acute Lymphoblastic Leukemia(ALL) A Children’s Oncology Group Study. (2005) (6)
- Nelarabine Can Be Safely Incorporated into an Intensive, Multiagent Chemotherapy Regimen for the Treatment of T-Cell Acute Lymphocytic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL00P2 Protocol for T-Cell Leukemia. (2006) (6)
- Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL). (1977) (6)
- Treatment of High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL): Comparison of Recent Experience of the Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG). (2004) (6)
- Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905 (2019) (6)
- Congenital neutropenia: Studies of pathogenesis (1980) (6)
- Intermediate-Dose Methotrexate and Intravenous 6-Mercaptopurine Chemotherapy for Children With Acute Lymphoblastic Leukemia Who Did Not Respond to Initial Induction Therapy (2002) (5)
- A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL). (2005) (5)
- T-cell/histiocyte-rich large B-cell lymphoma in pediatric patients: an under-recognized entity? (2015) (5)
- Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients. (1995) (5)
- Outcome of Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Standard Risk (SR) Features: Results of CCG-1952, CCG-1991 and POG 9404. (2004) (5)
- Nephroblastoma (Wilms tumor): tubule density and prognosis. (1978) (5)
- A Report of the Event-Free Survival (EFS) and Neurotoxicity for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) on Pediatric Oncology Group (POG) Protocol 9405. (2005) (5)
- Changes in the Delivery of Standard Chemotherapeutic Agents during Induction Affect Early Measures of Minimal Residual Disease (MRD): POG 9900 for Patients with B-Precursor Low and Standard Risk ALL. (2006) (5)
- Great oaks from little acorns (2004) (5)
- Role of Methotrexate in the Treatment of Acute Lymphoblastic Leukemia (2003) (5)
- Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation. (1985) (5)
- Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine. (1986) (5)
- Recent approaches to the treatment of acute lymphocytic leukemia in childhood. (1981) (5)
- Sequential Oral Hydroxyurea and Intravenous Cytosine Arabinoside in Refractory Childhood Acute Leukemia: A Pediatric Oncology Group Phase 1 Study (2008) (5)
- Mycobacterium avium intracellulare Infection Coexistent With Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Lung (2011) (3)
- PROGNOSTIC FACTORS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) (1977) (3)
- Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy. (1981) (3)
- Abnormalities of Lymphatic Vessels (2011) (3)
- Nelarabine in combination with intensive modified BFM AALL00P2: A pilot study for the treatment of high risk T-ALL a report from the Children’s Oncology Group (2008) (3)
- Prognostic value of antibody-dependent assays for presensitization in bone marrow transplant recipients. (1978) (3)
- Editors have ethical responsibilities, too. (1984) (3)
- Comparison of the biology of Down syndrome (DS) acute lymphoblastic leukemia (ALL) and non-DS ALL: Children's Oncology Group (COG) study P9900 (2008) (3)
- Successful treatment of recurrent CNS disease post‐bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis (2016) (3)
- Secondary Chromosomal Abnormalities Appear to Be Less Prognostic for Children with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with Intensified Imatinib and Chemotherapy: Results of the Children's Oncology Group (COG) Study AALL0031. (2009) (3)
- INTENSIVE POST-REMISSION INDUCTION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN AND ADULTS (1984) (3)
- Childhood primary cutaneous non‐T/non‐B lymphoma followed by acute T‐cell leukemia (1986) (3)
- Anemia in adolescence. 1. Disturbances of iron balance. (1975) (3)
- A Report of the Event Free Survival (EFS) for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) Treated on Pediatric Oncology Group (POG) Protocol 9605. (2005) (3)
- A controlled prospective trial of antithoracic duct lymphocyte globulin (ATDLG) for treatment of severe aplastic anemia. (1984) (3)
- BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA USING A PHENOTYPICALLY HLA‐IDENTICAL, SBCOMPATIBLE UNRELATED DONOR (1983) (2)
- Pathogenesis and Treatment of Aplastic Anemia (日本臨床血液学会第25回総会′83東京) (1984) (2)
- PEDIATRIC BONE MARROW TRANSPLANTATION-A BIO-ETHICAL MODEL (1974) (2)
- Anemia in adolescence. 2. Hemoglobinopathies and other causes. (1975) (2)
- Chemotherapy for Initial Induction Failures in Childhood Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study (POG 8764) (2013) (2)
- The treatment of acute myelogenous leukemia in children and adults: VAPA update. (1983) (2)
- Anatomy and Function of the Lymphatic System (2011) (2)
- Treatment of recurrent CNS disease post‐bone marrow transplant in familial HLH (2012) (2)
- Recombinant urate oxidase corrects hyperuricemia in patients treated for leukemia or lymphoma (1998) (2)
- Reply: Immunophenotypic prediction of TEL-AML1 rearrangement in childhood ALL (1999) (2)
- Possible Advantage of Twice-Daily 6-Mercaptopurine Dosing in Children with Acute Lymphoblastic Leukemia (ALL). (2007) (1)
- Thrombotic and Hemorrhagic Events for Patients on Pediatric Oncology Group (POG) Protocols 9201, 9605, 9406. (2005) (1)
- Philadelphia Chromosome Negative (Ph-) Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents: The Impact of Intensified Chemotherapy on Early Event Free Survival (EFS) in Children’s Oncology Group (COG) Study AALL0031. (2008) (1)
- The surgeon's role in pediatric orbital malignancies: an oncologist's perspective. (2003) (1)
- Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia? (2006) (1)
- Prognostic Factors and Patterns of Failure in Childhood Acute Myeloid Leukemia: Experience on Pediatric Oncology Group Study # 8821 (2001) (1)
- Bone marrow transplantation of a patient with aplastic anemia from a HLA-identical unrelated donor (1982) (1)
- Anatomy and Function of the Spleen (2011) (1)
- Genome-Wide Association Study Identifies a Novel Susceptibility Locus At 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethinically Diverse Populations (2012) (1)
- A Comparison Study of Parental Adaptation Following a Child's Death at Home or in the Hospital (1983) (1)
- ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study (2010) (1)
- Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL-ENL, and gene Expression Profiles Determine Obatoclax IC50: A Report on the Children's Oncology Group (COG) P9407 Trial (2010) (1)
- Children ' s Cancer Group lymphoblastic leukemia : a combined analysis of prognostic markers Risk-and response-based classification of childhood B-precursor acute (2007) (1)
- Appendix : supplementary information : gene expression profiling reveals novel genes for improved risk classification and outcome prediction in pediatric acute lymphoblastic leukemia : identification, validation, and cloning of OPAL1. (2004) (1)
- Heterogeneity of treatment outcome in children with Philadelphia chromosome-positive acute lymphoblastic leukemia (1999) (1)
- Doxorubicin-vincristine therapy for Wilms' tumor: a pilot study. (1982) (1)
- Setting up a pediatric oncology program in Cambodia: successes and challenges (2017) (1)
- Management of children with cancer. (1987) (1)
- Mutational Analysis of BCR-Abl From Subjects with Relapsed Ph+ALL Treated On the COG Protocol AALL0031: a Report From the Children's Oncology Group. (2009) (1)
- 60: Outcomes After Hematopoietic Stem Cell Transplant (HSCT) for Non-Hodgkin Lymphoma (NHL) in Children and Adolescents (2008) (1)
- Does intraveneous 6‐mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia? (2006) (1)
- pediatric B-precursor acute lymphoblastic leukemia residual disease improve risk classification and outcome prediction in Gene expression classifiers for relapse-free survival and minimal (2010) (1)
- Pyrite or true gold? (2005) (1)
- Colonel Mustard, with the rope, in the ballroom (2006) (1)
- Outcome of Transplantation for Acute Leukemia in Down Syndrome (2012) (0)
- Prospective Analysis of TEL and MLL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study. (2006) (0)
- relapse and survival Marrow transplantation for acute lymphoblastic leukemia: factors affecting (2011) (0)
- Pyrite or true gold? (2005) (0)
- Successful treatment of pediatric CML in Cambodia: an international collaboration (2017) (0)
- A.L.G. IN APLASTIC ANÆMIA (1978) (0)
- Clinical Bone Marrow and Blood Stem Cell Transplantation (2004) (0)
- Oncology Group Study disease in pediatric acute lymphoblastic leukemia: a Children's , and minimal residual (2012) (0)
- Reply to A. Bleyer et al (2012) (0)
- Comparison of Diagnostic and Relapse Flow Cytometry Phenotypes in Childhood ALL: Implications for Residual Disease (MRD) Detection. (2004) (0)
- CELL WALL COMPOSITION AND VIRULENCE I N ESCHERICHIA COLI*, (2003) (0)
- Utility of end consolidation bone marrow aspirates in childhood acute lymphoblastic leukemia [ALL]: A Pediatric Oncology Group study [POG]. (2004) (0)
- RISK FACTORS AFFECTING OUTCOME OF SECOND HLA-MATCHED SIBLING DONOR TRANSPLANTS FOR GRAFT FAILURE IN SEVERE ACQUIRED APLASTIC ANEMIA (2009) (0)
- Pathogenesis of severe aplastic anemia: inferences from therapeutic trials. (1979) (0)
- Pathogenesis and Treatment of Acute Lymphocytic Leukemia in Infants (2004) (0)
- Childhood A cute L ymphoblastic L eukemia W ith t he MLL-ENL Fusion a nd t (11;19)(q23;p13 .3) T ranslocation (1999) (0)
- Hepatotoxicty in Standard Risk B-Cell Precursor Pediatric Acute Lymphoblastic Leukemia Patients Treated On Pediatric Oncology Group (POG) Protocol 9605. (2009) (0)
- Faculty Opinions recommendation of Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. (2008) (0)
- A determination of the antigenic differences or similarities of C57Bl/6 and WB and WC mice by reciprocal skin transplantation. (1958) (0)
- Reply to: Graft-versus-host reaction after leukocyte transfusion (1994) (0)
- KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study. (2023) (0)
- Predictive of Treatment Outcome in Childhood Acute Lymphoblastic Chimeric Transcript Status at End of Consolidation Is Not E 2 A-PBX (1998) (0)
- Recombinant U rate O xidase f or t he P rophylaxis o r Treatment o f H yperuricemia i n P atients W ith L eukemia or L ymphoma (2001) (0)
- Pyrites: An Episcleral Mass. (2021) (0)
- Acute erythroid hypoplasia in malnourished Infant sq uirrel mo nkeys fed isolated soy (1977) (0)
- Long Term Outcomes of Unrelated Donor Bone Marrow Transplantation in Children with Severe Aplastic Anemia: An Update of the Milwaukee Experience. (2006) (0)
- Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia (2011) (0)
- Hematopoietic cell transplants for children with acute lymphoblastic leukemia (2017) (0)
- controlled study of conditioning regimens Bone marrow transplantation for severe aplastic anemia: a randomized (2013) (0)
- THE CLOSE ASSOCIATION BETWEEN ACCELERATED RATES OF WHOLE BODY PROTEIN SYNTHESIS(S) AND BASAL METABOLIC RATE (BMR) IN CHILDREN WITH NEWLY DIAGNOSED ACUTE LYMPHOCYTIC LEUKEMIA (ALL) (1984) (0)
- Molecular Classifiers for Prediction of Minimal Residual Disease (MRD) and Event Free Survival (EFS) Improve Risk Assignment at Diagnosis in Pediatric High-Risk B Precursor Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group Study. (2007) (0)
- GRAFT-VERSUS-HOST REACTION AFTER LEUKOCYTE TRANSFUSION. AUTHOR'S REPLY (1994) (0)
- Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study. (2007) (0)
- Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience (2011) (0)
- Current therapy of childhood osteosarcoma and Ewing's sarcoma. (1980) (0)
- A study of the possible pleiotropic effects of the gene for maltese dilution in the mouse. (1958) (0)
- More and more about less and less (2005) (0)
- Cell wall composition and virulence in E. coli. II. Studies of a phosphomannose isomerase-deficient mutant (L-2) of E. coli 0111 (1965) (0)
- TREATMENT OF RHABDOMYOSARCOMA. AUTHORS' REPLY (1996) (0)
- Treatment of rhabdomyosarcoma. (1996) (0)
- Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study (2010) (0)
- Inherited GATA3 genetic Variants Are Associated With Childhood BCR-ABL1-Like Acute Lymphoblastic Leukemia and Increased Risk Of Relapse (2013) (0)
- lymphoblastic leukemia: a report from the Children's Oncology Group Key pathways are frequently mutated in high-risk childhood acute (2013) (0)
- Outcome Predictor in Acute Leukemia 1 (OPAL1) Predicts Outcome in Pediatric Acute Lymphoblastic Leukemia in Multiple Independent Gene Expression Data Sets: Effects of Binary Binning, a Statistical Approach (2007) (0)
- Racial D ifferences i n t he S urvival o f C hildhood B - Precursor A cute L ymphoblastic L eukemia: A P ediatric Oncology G roup S tudy (2000) (0)
- pediatric B-progenitor acute lymphoblastic leukemia , Hispanic / Latino ethnicity , and a poor outcome in IKZF 1 alteration of kinases , JAK is associated with mutation of CRLF 2 Rearrangement of (2010) (0)
- Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles ( 90 Days): A Children's Oncology Group Study (2010) (0)
- Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia. (2007) (0)
- Pyrite or true gold? Case 1. (2005) (0)
- #513 Infant ALL‐A Pilot Study: Improved outcome with induction intensification (1996) (0)
- Risk-Adapted Therapy for Acute Lymphocytic Leukemia: The Pediatric Oncology Group Experience (1997) (0)
- Glucocorticoid resistance: a persistent riddle (2006) (0)
- 1537 RENAL INVOLVEMENT IN FANCONI'S HYPOPLASTIC ANEMIA (1981) (0)
- A Comparison of Hepatotoxicity and Neutropenia in Children Given Oral Mercaptopurine on a Twice-Daily Versus Once-Daily Dosing Schedule for Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study. (2004) (0)
- Utility of end consolidation bone marrow aspirates in childhood acute lymphoblastic leukemia [ALL]: A Pediatric Oncology Group study [POG] (2004) (0)
- Tribute to Bart Kamen. (2012) (0)
- 637 – HUMAN PHARMACOLOGY OF SUCCINYLATED ACINETOBACTER GLUTAMINASE-ASPARAGINASE (1978) (0)
- The medical ethics of bone marrow transplantation in childhood. (1975) (0)
- Testicular Relapse in Lesser, Standard, and High Risk Patients Treated with Frontline Therapy for Childhood ALL. Pediatric Oncology Group Protocols 9201, 9405, 9605, and 9406. (2006) (0)
- A.L.G. in aplastic anaemia. (1978) (0)
- Working Party Aplastic Anaemia (2001) (0)
- High Dose Chemotherapy With Blood or Marrow Transplant for Rhabdomyosarcoma: A CIBMTR Analysis (2009) (0)
- Editor's mail. (1975) (0)
- Delayed leucovorin rescue after high dose methotrexate (HDMTX) in children (1977) (0)
- Comparison o f P reparative R egimens i n T ransplants f or Children W ith A cute L ymphoblastic L eukemia (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bruce M. Camitta?
Bruce M. Camitta is affiliated with the following schools:
